Trump's Drug Price Cut Letters Rattling European Drugmakers

Trump's Demand for Lower Drug Prices

• ✉️ President Trump sent letters to major pharmaceutical firms, urging them to cut drug prices in the United States.
• 🗓️ This action follows an executive order signed months prior, aimed at lowering prescription drug costs.
• 💰 The letters specifically requested companies to provide "most favored nation" prices for the government's Medicaid program and for new drugs.
• ⏳ Companies have until September 29th to respond with binding commitments to these terms.

Market Reaction and Industry Response

• 📉 Shares of European drugmakers experienced a decline, with the European healthcare index falling to its lowest point since April.
• 💸 The industry is also contending with tariffs from a recent US-EU trade deal, potentially costing between 13 and 19 billion.
• 🧐 An analyst noted that it's uncertain if Trump will change his stance if drug makers engage with him.
• 🤝 Some companies, like Fizer and Merc KGAA's US division, expressed openness to working with the Trump administration.
• 🚫 However, lobbyists and experts consider it unlikely that pharmaceutical companies will comply with the demand to lower US prices.

Previous Executive Action and Company Strategies

• ⚖️ Trump's May executive order aimed to align US drug prices with those paid in other countries.
• 💡 In response to pricing pressures, Swiss pharmaceutical ro indicated it might sell prescription drugs directly to consumers in the US to reduce costs.